Biomarker for Progression in Breast tagged posts

New Biomarker for Progression in Breast, Prostate Cancers ID’d: holds promise for treating disease

DIAPH3 silencing reduces the population of stable MT and alters MT topology. NB. Inhibition of MT stability arising from DIAPH3 downregulation enhances susceptibility to MT poisons, and that the DIAPH3 network potentially reports taxane sensitivity in human

DIAPH3 silencing reduces the population of stable MT and alters MT topology. NB. Inhibition of MT stability arising from DIAPH3 downregulation enhances susceptibility to MT poisons, and that the DIAPH3 network potentially reports taxane sensitivity in human

The biomarker – diaphanous-related formin-3 or DIAPH3 – participates in a protein interaction that makes cells rigid. The study found that when this biomarker is lost or lowered, cells become “deformable,” squeezing through tissue spaces, causing disease growth or progression. This phenomenon is known as an amoeboid phenotype.

ie DIAPH3 interacted with microtubules (MT), and its loss altered several parameters of MT dynamics as well as decreased polarized force generation, contractility, and response to substrate stiffness...

Read More